Isabelle Solomon

1.7k total citations
4 papers, 45 citations indexed

About

Isabelle Solomon is a scholar working on Oncology, Immunology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Isabelle Solomon has authored 4 papers receiving a total of 45 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Oncology, 4 papers in Immunology and 2 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Isabelle Solomon's work include Cancer Immunotherapy and Biomarkers (4 papers), Immunotherapy and Immune Responses (3 papers) and Monoclonal and Polyclonal Antibodies Research (2 papers). Isabelle Solomon is often cited by papers focused on Cancer Immunotherapy and Biomarkers (4 papers), Immunotherapy and Immune Responses (3 papers) and Monoclonal and Polyclonal Antibodies Research (2 papers). Isabelle Solomon collaborates with scholars based in United Kingdom and Israel. Isabelle Solomon's co-authors include Ignacio Matos, Tomer Landsberger, Ido Amit, Oren Barboy, Karl S. Peggs, Adam Yalin, Eyal David, Ido Yofe, Sergio A. Quezada and Mansi Shah and has published in prestigious journals such as Cancer Research, Cancer Immunology Research and Nature Cancer.

In The Last Decade

Isabelle Solomon

4 papers receiving 45 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Isabelle Solomon United Kingdom	2	37	30	9	7	6	4	45
Gwendoline Grondin France	3	54 1.5×	47 1.6×	11 1.2×	13 1.9×	4 0.7×	3	67
Alejandro Allo Anido United States	3	20 0.5×	34 1.1×	4 0.4×	14 2.0×	13 2.2×	3	45
John Srouji United States	3	34 0.9×	27 0.9×	11 1.2×	19 2.7×	2 0.3×	3	44
Andrea Mahr Germany	2	22 0.6×	18 0.6×	4 0.4×	17 2.4×	3 0.5×	2	28
Jongchan Choi United States	3	21 0.6×	14 0.5×	5 0.6×	13 1.9×	13 2.2×	3	37
Loes Plaisier Netherlands	2	24 0.6×	23 0.8×	20 2.2×	15 2.1×	5 0.8×	2	45
Nolan R. Vale United States	3	24 0.6×	30 1.0×	5 0.6×	7 1.0×		3	33
Hongming Pan China	2	16 0.4×	14 0.5×	4 0.4×	10 1.4×	3 0.5×	5	26
Tomohiro Iida Japan	4	27 0.7×	26 0.9×	8 0.9×	4 0.6×		7	50
Carl Watson Switzerland	3	33 0.9×	25 0.8×	3 0.3×	6 0.9×	4 0.7×	3	49

Countries citing papers authored by Isabelle Solomon

Since Specialization

Citations

This map shows the geographic impact of Isabelle Solomon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Isabelle Solomon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Isabelle Solomon more than expected).

Fields of papers citing papers by Isabelle Solomon

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Isabelle Solomon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Isabelle Solomon. The network helps show where Isabelle Solomon may publish in the future.

Co-authorship network of co-authors of Isabelle Solomon

This figure shows the co-authorship network connecting the top 25 collaborators of Isabelle Solomon. A scholar is included among the top collaborators of Isabelle Solomon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Isabelle Solomon. Isabelle Solomon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

4 of 4 papers shown

1.

Yofe, Ido, Tomer Landsberger, Adam Yalin, et al.. (2022). Anti-CTLA-4 antibodies drive myeloid activation and reprogram the tumor microenvironment through FcγR engagement and type I interferon signaling. Nature Cancer. 3(11). 1336–1350. 41 indexed citations

2.

Goubier, Anne, Isabelle Solomon, Frederick Arce Vargas, et al.. (2019). Abstract A192: Non-IL-2 blocking anti-CD25-targeting antibodies: depletion of regulatory T-cells driving optimal effector response for rejection of established tumors. Cancer Immunology Research. 7(2_Supplement). A192–A192. 1 indexed citations

3.

Salimu, Josephine, Pascal Merchiers, Beatriz Goyenechea, et al.. (2018). Abstract 2787: Generation of first-in-class anti-CD25 antibodies depleting Treg without interfering with IL2 signalling for cancer therapies. Cancer Research. 78(13_Supplement). 2787–2787. 1 indexed citations

4.

Solomon, Isabelle, Frederick Arce Vargas, Qing Chen, et al.. (2018). Abstract 3143: A novel approach to deplete Treg cells using non-IL-2 blocking anti-CD25-targeting antibodies leads to complete rejection of established tumors. Cancer Research. 78(13_Supplement). 3143–3143. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact